Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study

Cancer Chemotherapy and Pharmacology
J C CervellinoR Rossi

Abstract

This study was carried out to assess the efficacy of high-dose ifosfamide/mesna (HDIFM) in the treatment of advanced or recurrent cancer of the cervix. In all, 18/21 evaluable patients with advanced or inoperable cervical cancer were included. The mean age was 42 years (range, 31-58 years); and the International Federation of Gynecology and Obstetrics (FIGO) stage was III in 10 patients and IV in 11. The Karnofsky performance status ranged between 70 and 90, with a median of 77. Ten patients had previously been treated with surgery, radium and cobalt (8) or cobalt alone (2). Therapy consisted of 3.5 g/m2, ifosfamide (IFO) given in an 8-h i.v. infusion on days 1-5 and mesna at 20% of the IFO dose, given i.v. at 0, 2, 4, 6 and 8 h, followed by mesna at 40% of the IFO dose by the oral route at 10 and 12 h on days 1-5. For evaluation purposes, patients received at least two cycles. Toxicity was registered in 137 cycles and was mild to moderate. Three complete (16.6%) and six partial (33.3%) responses were observed (50%), but 66% of them occurred in areas that had not previously been irradiated. The median duration of response was 14 months and the overall median survival was 15+ months (18+ months for responders). The Karnofsky sca...Continue Reading

References

Apr 1, 1975·Clinical Pharmacology and Therapeutics·L M Allen, P J Creaven
Jan 1, 1990·Cancer Chemotherapy and Pharmacology·G BlackledgeC A Meanwell
Jan 1, 1988·Cancer Investigation·N BrockH Sindermann
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·R E ColemanC W Trask

❮ Previous
Next ❯

Citations

Jan 1, 1991·Journal of Cancer Research and Clinical Oncology·W P BradeC E Araujo
Jan 1, 1995·La Revue de médecine interne·D Zylberait
Feb 25, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N KatsumataK Ochiai
Jul 29, 2008·Cancer Treatment Reviews·D PectasidesE Pectasides
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A. N. J. TuttP. R. Blake
Aug 20, 2002·The Oncologist·Alexander I Spira, David S Ettinger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.